Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease
- Conditions
- Intestinal Disease
- Interventions
- Diagnostic Test: Iron status testing
- Registration Number
- NCT04123990
- Lead Sponsor
- VIFORFRANCE
- Brief Summary
Despite its known prevalence in IBD, a recent study conducted with Prof. Cacoub (unpublished) on the national health insurance database showed that iron deficiency was an under-diagnosed and under-treated co-morbidity. In chronic diseases including IBD, Transferrin Saturation Factor is only performed in approximately 10% of cases, whereas it is recommended in inflammatory situations including IBD patients (HAS 2011).
The objective of this study is therefore to obtain updated French data on the prevalence of iron deficiency in patients with IBD by applying the recommendations of ECCO and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1100
- Patient, male or female, over 18 years old
- Patient present at the hospital on the day of the study
- Diagnosis of IBD on international criteria
- Patient giving written consent
- Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision;
- pregnant, lactating or parturient woman;
- Patient hospitalized without consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description IBD Iron status testing -
- Primary Outcome Measures
Name Time Method Ferritinemia according to inflammatory status One day Ferritinemia will be assessed from blood sample (iron status)
- Secondary Outcome Measures
Name Time Method